Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer

To elucidate the etiology of the thrombogenic effects of high‐dose medroxyprogesterone acetate (MPA) in the treatment of breast cancer, hematologic parameters were sequentially assessed in 12 patients receiving MPA 800 mg p.o. daily for 6 months as adjuvant hormone therapy after mastectomy. The resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Hitoshi, Noguchi, Shinzaburo, Miyauchi, Keisuke, Inaji, Hideo, Imaoka, Shingi, Koyama, Hiroki, Iwanaga, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1991
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918452/
https://www.ncbi.nlm.nih.gov/pubmed/1828463
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01865.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918452/
https://www.ncbi.nlm.nih.gov/pubmed/1828463
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01865.x

Ejemplares similares